Clinical trial
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN)…
NCT00231855 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00231855 |
|---|---|
| Title | Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers |
| Official title | Phase II Trial- Weekly Taxotere and Topotecan for Recurrent Ovarian, Primary Peritoneal, Endometrial and Uterine Cancers |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | Sanofi Industry GlaxoSmithKline |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Neoplasms, Uterine Neoplasms |
| Intervention type | Drug |
| Interventions | Topotecan and Taxotere |
| Enrollment | 31 |
| Start date | Nov 1, 2004 |
| Completion | Mar 1, 2007 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: